2024, Degenerative Disc Disease and Vertebrae

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2024

Degenerative Disc Disease

Vertebrae

Cerapedics Announces FDA Approval of PearlMatrix™ P-15 Peptide Enhanced Bone Graft, The First and Only Proven Bone Growth Accelerator for Lumbar Fusion

OrthoSpineNews

JUNE 23, 2025

Food and Drug Administration (FDA) premarket approval (PMA) of PearlMatrix P-15 Peptide Enhanced Bone Graft as a Class III drug-device combination product for use in single-level transforaminal lumbar interbody fusion (TLIF) surgery in adult patients with degenerative disc disease (DDD). Accessed August 2024.

Spinal Implants Market to Grow by USD 3.55 Billion from 2025-2029, Driven by Rising Spinal Disorder Prevalence, AI’s Impact on Market Trends – Technavio

OrthoSpineNews

FEBRUARY 10, 2025

Explore trends, segmentation, and growth drivers- View Free Sample PDF Spinal Implants Market Scope Report Coverage Details Base year 2024 Historic period 2019 – 2023 Forecast period 2025-2029 Growth momentum & CAGR Accelerate at a CAGR of 5.3% Key insights into market evolution with AI-powered analysis. JAYON IMPLANTS Pvt.

Degenerative Disc Disease

Degenerative Disc Disease Scoliosis Clients Spine

Chiropractic Pulse

Cerapedics Announces FDA Approval of PearlMatrix™ P-15 Peptide Enhanced Bone Graft, The First and Only Proven Bone Growth Accelerator for Lumbar Fusion

Spinal Implants Market to Grow by USD 3.55 Billion from 2025-2029, Driven by Rising Spinal Disorder Prevalence, AI’s Impact on Market Trends – Technavio

Stay Connected